MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹381 Cr | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹381 Cr |
| Mar2024 | ₹314 Cr |
| Mar2023 | ₹266 Cr |
| Mar2022 | ₹185 Cr |
| Mar2021 | ₹236 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹381 Cr | 21.32 | |
| Mar2024 | ₹314 Cr | 17.80 | |
| Mar2023 | ₹266 Cr | 44.29 | |
| Mar2022 | ₹185 Cr | -21.77 | |
| Mar2021 | ₹236 Cr | - | |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,212.2 Cr | 0.2% | 19.1% | -0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 0.2% |
19.1% |
-0.2% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses